CASTLE BIOSCIENCES, INC. Equity Securities, FV-NI, Realized Gain (Loss)
CASTLE BIOSCIENCES, INC. (CSTL) reported Equity Securities, FV-NI, Realized Gain (Loss) of -$386.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiRealizedGainLoss · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, realized gain (loss) for the quarter ending 2026-06-30 was -$386.00K.
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, realized gain (loss) for the quarter ending 2026-03-31 was -$127.00K.
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, realized gain (loss) for the quarter ending 2025-06-30 was $0.00.
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, realized gain (loss) for the quarter ending 2025-03-31 was $0.00.
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, realized gain (loss) for fiscal 2025 was $484.00K.
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, realized gain (loss) for fiscal 2024 was $0.00.
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, realized gain (loss) for fiscal 2023 was $0.00.
| Period end | Equity Securities, FV-NI, Realized Gain (Loss) 3 month | Equity Securities, FV-NI, Realized Gain (Loss) 6 month | Equity Securities, FV-NI, Realized Gain (Loss) 12 month |
|---|---|---|---|
| 2026-06-30 | -$386.00K 10-Q · filed 2026-07-30 | -$513.00K 10-Q · filed 2026-07-30 | |
| 2026-03-31 | -$127.00K 10-Q · filed 2026-05-06 | ||
| 2025-12-31 | $484.00K 10-K · filed 2026-02-26 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-07-30 | $0.00 10-Q · filed 2026-07-30 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-06 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 | ||
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |